MR1-3
Resource Report
Resource Website
|
RRID:CVCL_U180
|
Homo sapiens (Human)
|
Human papillomavirus-related endocervical adenocarcinoma
|
Population: African American.
|
PMID:2372878 PMID:3608093 PMID:25877200
|
Cancer cell line
|
Female |
|
|
|
CLO:CLO_0050915, BioSample:SAMN03470994, Cosmic:753593, RCB:RCB0504, Wikidata:Q54906568 |
cvcl_u209 |
|
CVCL_U180 |
2026-09-12 05:49:22 |
0 |
MRC-5
Resource Report
Resource Website
1000+ mentions
Discontinued
|
ICLC Cat# HL95001, RRID:CVCL_0440
|
Homo sapiens (Human)
|
|
Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Senescence: Capable of attaining 42-46 population doublings before the onset of senescence (ATCC=CCL-171). Senesces at 26 PDL (PubMed=17395773)., Biotechnology: Used for the production of the live zoster vaccine (Trade name: Zostavax)., Biotechnology: Used for the production of the live varicella virus vaccine (Trade name: Varivax)., Biotechnology: Used for the production of the Hepatitis A vaccines Avaxim, Epaxal, Havrix and Vaqta., Biotechnology: Used for the production of the Human Diploid Cell Vaccine (HDCV) against rabies (Trade name: Imovax Rabies)., Group: Vaccine production cell line.
|
PMID:113411 PMID:211143 PMID:932048 PMID:1031681 PMID:1193162 PMID:1756776 PMID:1965304 PMID:3335022 PMID:4316953 PMID:6538202 PMID:6971834 PMID:7065527 PMID:10752125 PMID:11416159 PMID:17395773 PMID:19657000 PMID:21637780 PMID:25877200 PMID:25903999 PMID:26477663 PMID:31869419 PMID:33389257
|
Finite cell line
|
Male |
MRC5, MRC 5, MRCV, MRC-V, Medical Research Council cell strain-5 |
ICLC |
HL95001 |
BTO:BTO_0001590, CLO:CLO_0007865, CLO:CLO_0050055, EFO:EFO_0002835, MCCL:MCC:0000336, CLDB:cl3563, CLDB:cl3564, CLDB:cl3566, CLDB:cl3567, CLDB:cl3568, CLDB:cl5168, AddexBio:T0016002/4922, ATCC:CCL-171, BCRC:60023, BCRJ:0180, BioSample:SAMN01821580, BioSample:SAMN01821702, BioSample:SAMN01821735, BioSample:SAMN03473183, CCRID:1101HUM-PUMC000044, CCRID:1102HUM-NIFDC00002, CCRID:3101HUMGNHu41, CCRID:3101HUMSCSP5040, CCRID:4201HUM-CCTCC00032, CCRID:5301HUM-KCB89023YJ, CCTCC:GDC0032, ChEMBL-Cells:CHEMBL3308499, ChEMBL-Targets:CHEMBL614181, CLS:300395, ECACC:97112601, FCS-free:179-2-338-1-16-3, GEO:GSM248209, GEO:GSM248210, GEO:GSM520665, GEO:GSM520666, GEO:GSM520667, GEO:GSM579888, GEO:GSM579889, GEO:GSM607969, GEO:GSM3738752, GEO:GSM3738753, IBRC:C10313, ICLC:HL95001, IZSLER:BS CL 68, JCRB:IFO50073, JCRB:JCRB9008, KCB:KCB 200412YJ, KCB:KCB 89023YJ, KCLB:10171, Lonza:52, NCBI_Iran:C125, PRIDE:PXD001909, PRIDE:PXD013120, PRIDE:PXD023286, PubChem_Cell_line:CVCL_0440, RCB:RCB0211, RCB:RCB0218, Wikidata:Q3273166 |
|
|
CVCL_0440 |
2026-09-12 05:49:22 |
2876 |
MRC-5
Resource Report
Resource Website
1000+ mentions
Discontinued
|
RCB Cat# RCB0211, RRID:CVCL_0440
|
Homo sapiens (Human)
|
|
Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Senescence: Capable of attaining 42-46 population doublings before the onset of senescence (ATCC=CCL-171). Senesces at 26 PDL (PubMed=17395773)., Biotechnology: Used for the production of the live zoster vaccine (Trade name: Zostavax)., Biotechnology: Used for the production of the live varicella virus vaccine (Trade name: Varivax)., Biotechnology: Used for the production of the Hepatitis A vaccines Avaxim, Epaxal, Havrix and Vaqta., Biotechnology: Used for the production of the Human Diploid Cell Vaccine (HDCV) against rabies (Trade name: Imovax Rabies)., Group: Vaccine production cell line.
|
PMID:113411 PMID:211143 PMID:932048 PMID:1031681 PMID:1193162 PMID:1756776 PMID:1965304 PMID:3335022 PMID:4316953 PMID:6538202 PMID:6971834 PMID:7065527 PMID:10752125 PMID:11416159 PMID:17395773 PMID:19657000 PMID:21637780 PMID:25877200 PMID:25903999 PMID:26477663 PMID:31869419 PMID:33389257
|
Finite cell line
|
Male |
MRC5, MRC 5, MRCV, MRC-V, Medical Research Council cell strain-5 |
RCB |
RCB0211 |
BTO:BTO_0001590, CLO:CLO_0007865, CLO:CLO_0050055, EFO:EFO_0002835, MCCL:MCC:0000336, CLDB:cl3563, CLDB:cl3564, CLDB:cl3566, CLDB:cl3567, CLDB:cl3568, CLDB:cl5168, AddexBio:T0016002/4922, ATCC:CCL-171, BCRC:60023, BCRJ:0180, BioSample:SAMN01821580, BioSample:SAMN01821702, BioSample:SAMN01821735, BioSample:SAMN03473183, CCRID:1101HUM-PUMC000044, CCRID:1102HUM-NIFDC00002, CCRID:3101HUMGNHu41, CCRID:3101HUMSCSP5040, CCRID:4201HUM-CCTCC00032, CCRID:5301HUM-KCB89023YJ, CCTCC:GDC0032, ChEMBL-Cells:CHEMBL3308499, ChEMBL-Targets:CHEMBL614181, CLS:300395, ECACC:97112601, FCS-free:179-2-338-1-16-3, GEO:GSM248209, GEO:GSM248210, GEO:GSM520665, GEO:GSM520666, GEO:GSM520667, GEO:GSM579888, GEO:GSM579889, GEO:GSM607969, GEO:GSM3738752, GEO:GSM3738753, IBRC:C10313, ICLC:HL95001, IZSLER:BS CL 68, JCRB:IFO50073, JCRB:JCRB9008, KCB:KCB 200412YJ, KCB:KCB 89023YJ, KCLB:10171, Lonza:52, NCBI_Iran:C125, PRIDE:PXD001909, PRIDE:PXD013120, PRIDE:PXD023286, PubChem_Cell_line:CVCL_0440, RCB:RCB0211, RCB:RCB0218, Wikidata:Q3273166 |
|
|
CVCL_0440 |
2026-09-12 05:49:22 |
2876 |
MRC-5
Resource Report
Resource Website
1000+ mentions
Discontinued
|
BCRJ Cat# 0180, RRID:CVCL_0440
|
Homo sapiens (Human)
|
|
Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Senescence: Capable of attaining 42-46 population doublings before the onset of senescence (ATCC=CCL-171). Senesces at 26 PDL (PubMed=17395773)., Biotechnology: Used for the production of the live zoster vaccine (Trade name: Zostavax)., Biotechnology: Used for the production of the live varicella virus vaccine (Trade name: Varivax)., Biotechnology: Used for the production of the Hepatitis A vaccines Avaxim, Epaxal, Havrix and Vaqta., Biotechnology: Used for the production of the Human Diploid Cell Vaccine (HDCV) against rabies (Trade name: Imovax Rabies)., Group: Vaccine production cell line.
|
PMID:113411 PMID:211143 PMID:932048 PMID:1031681 PMID:1193162 PMID:1756776 PMID:1965304 PMID:3335022 PMID:4316953 PMID:6538202 PMID:6971834 PMID:7065527 PMID:10752125 PMID:11416159 PMID:17395773 PMID:19657000 PMID:21637780 PMID:25877200 PMID:25903999 PMID:26477663 PMID:31869419 PMID:33389257
|
Finite cell line
|
Male |
MRC5, MRC 5, MRCV, MRC-V, Medical Research Council cell strain-5 |
BCRJ |
0180 |
BTO:BTO_0001590, CLO:CLO_0007865, CLO:CLO_0050055, EFO:EFO_0002835, MCCL:MCC:0000336, CLDB:cl3563, CLDB:cl3564, CLDB:cl3566, CLDB:cl3567, CLDB:cl3568, CLDB:cl5168, AddexBio:T0016002/4922, ATCC:CCL-171, BCRC:60023, BCRJ:0180, BioSample:SAMN01821580, BioSample:SAMN01821702, BioSample:SAMN01821735, BioSample:SAMN03473183, CCRID:1101HUM-PUMC000044, CCRID:1102HUM-NIFDC00002, CCRID:3101HUMGNHu41, CCRID:3101HUMSCSP5040, CCRID:4201HUM-CCTCC00032, CCRID:5301HUM-KCB89023YJ, CCTCC:GDC0032, ChEMBL-Cells:CHEMBL3308499, ChEMBL-Targets:CHEMBL614181, CLS:300395, ECACC:97112601, FCS-free:179-2-338-1-16-3, GEO:GSM248209, GEO:GSM248210, GEO:GSM520665, GEO:GSM520666, GEO:GSM520667, GEO:GSM579888, GEO:GSM579889, GEO:GSM607969, GEO:GSM3738752, GEO:GSM3738753, IBRC:C10313, ICLC:HL95001, IZSLER:BS CL 68, JCRB:IFO50073, JCRB:JCRB9008, KCB:KCB 200412YJ, KCB:KCB 89023YJ, KCLB:10171, Lonza:52, NCBI_Iran:C125, PRIDE:PXD001909, PRIDE:PXD013120, PRIDE:PXD023286, PubChem_Cell_line:CVCL_0440, RCB:RCB0211, RCB:RCB0218, Wikidata:Q3273166 |
|
|
CVCL_0440 |
2026-09-12 05:49:22 |
2876 |
MRC-5
Resource Report
Resource Website
1000+ mentions
Discontinued
|
RCB Cat# RCB0218, RRID:CVCL_0440
|
Homo sapiens (Human)
|
|
Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Senescence: Capable of attaining 42-46 population doublings before the onset of senescence (ATCC=CCL-171). Senesces at 26 PDL (PubMed=17395773)., Biotechnology: Used for the production of the live zoster vaccine (Trade name: Zostavax)., Biotechnology: Used for the production of the live varicella virus vaccine (Trade name: Varivax)., Biotechnology: Used for the production of the Hepatitis A vaccines Avaxim, Epaxal, Havrix and Vaqta., Biotechnology: Used for the production of the Human Diploid Cell Vaccine (HDCV) against rabies (Trade name: Imovax Rabies)., Group: Vaccine production cell line.
|
PMID:113411 PMID:211143 PMID:932048 PMID:1031681 PMID:1193162 PMID:1756776 PMID:1965304 PMID:3335022 PMID:4316953 PMID:6538202 PMID:6971834 PMID:7065527 PMID:10752125 PMID:11416159 PMID:17395773 PMID:19657000 PMID:21637780 PMID:25877200 PMID:25903999 PMID:26477663 PMID:31869419 PMID:33389257
|
Finite cell line
|
Male |
MRC5, MRC 5, MRCV, MRC-V, Medical Research Council cell strain-5 |
RCB |
RCB0218 |
BTO:BTO_0001590, CLO:CLO_0007865, CLO:CLO_0050055, EFO:EFO_0002835, MCCL:MCC:0000336, CLDB:cl3563, CLDB:cl3564, CLDB:cl3566, CLDB:cl3567, CLDB:cl3568, CLDB:cl5168, AddexBio:T0016002/4922, ATCC:CCL-171, BCRC:60023, BCRJ:0180, BioSample:SAMN01821580, BioSample:SAMN01821702, BioSample:SAMN01821735, BioSample:SAMN03473183, CCRID:1101HUM-PUMC000044, CCRID:1102HUM-NIFDC00002, CCRID:3101HUMGNHu41, CCRID:3101HUMSCSP5040, CCRID:4201HUM-CCTCC00032, CCRID:5301HUM-KCB89023YJ, CCTCC:GDC0032, ChEMBL-Cells:CHEMBL3308499, ChEMBL-Targets:CHEMBL614181, CLS:300395, ECACC:97112601, FCS-free:179-2-338-1-16-3, GEO:GSM248209, GEO:GSM248210, GEO:GSM520665, GEO:GSM520666, GEO:GSM520667, GEO:GSM579888, GEO:GSM579889, GEO:GSM607969, GEO:GSM3738752, GEO:GSM3738753, IBRC:C10313, ICLC:HL95001, IZSLER:BS CL 68, JCRB:IFO50073, JCRB:JCRB9008, KCB:KCB 200412YJ, KCB:KCB 89023YJ, KCLB:10171, Lonza:52, NCBI_Iran:C125, PRIDE:PXD001909, PRIDE:PXD013120, PRIDE:PXD023286, PubChem_Cell_line:CVCL_0440, RCB:RCB0211, RCB:RCB0218, Wikidata:Q3273166 |
|
|
CVCL_0440 |
2026-09-12 05:49:22 |
2876 |
MR6
Resource Report
Resource Website
|
RCB Cat# RCB0505, RRID:CVCL_U183
|
Homo sapiens (Human)
|
Human papillomavirus-related endocervical adenocarcinoma
|
Population: African American.
|
PMID:2372878 PMID:3608093 PMID:25877200
|
Cancer cell line
|
Female |
|
RCB |
RCB0505 |
CLO:CLO_0050916, BioSample:SAMN03470988, BioSample:SAMN03472275, RCB:RCB0505, Wikidata:Q54906577 |
cvcl_u209 |
|
CVCL_U183 |
2026-09-12 05:49:22 |
0 |
MRC-5
Resource Report
Resource Website
1000+ mentions
Discontinued
|
BCRC Cat# 60023, RRID:CVCL_0440
|
Homo sapiens (Human)
|
|
Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Senescence: Capable of attaining 42-46 population doublings before the onset of senescence (ATCC=CCL-171). Senesces at 26 PDL (PubMed=17395773)., Biotechnology: Used for the production of the live zoster vaccine (Trade name: Zostavax)., Biotechnology: Used for the production of the live varicella virus vaccine (Trade name: Varivax)., Biotechnology: Used for the production of the Hepatitis A vaccines Avaxim, Epaxal, Havrix and Vaqta., Biotechnology: Used for the production of the Human Diploid Cell Vaccine (HDCV) against rabies (Trade name: Imovax Rabies)., Group: Vaccine production cell line.
|
PMID:113411 PMID:211143 PMID:932048 PMID:1031681 PMID:1193162 PMID:1756776 PMID:1965304 PMID:3335022 PMID:4316953 PMID:6538202 PMID:6971834 PMID:7065527 PMID:10752125 PMID:11416159 PMID:17395773 PMID:19657000 PMID:21637780 PMID:25877200 PMID:25903999 PMID:26477663 PMID:31869419 PMID:33389257
|
Finite cell line
|
Male |
MRC5, MRC 5, MRCV, MRC-V, Medical Research Council cell strain-5 |
BCRC |
60023 |
BTO:BTO_0001590, CLO:CLO_0007865, CLO:CLO_0050055, EFO:EFO_0002835, MCCL:MCC:0000336, CLDB:cl3563, CLDB:cl3564, CLDB:cl3566, CLDB:cl3567, CLDB:cl3568, CLDB:cl5168, AddexBio:T0016002/4922, ATCC:CCL-171, BCRC:60023, BCRJ:0180, BioSample:SAMN01821580, BioSample:SAMN01821702, BioSample:SAMN01821735, BioSample:SAMN03473183, CCRID:1101HUM-PUMC000044, CCRID:1102HUM-NIFDC00002, CCRID:3101HUMGNHu41, CCRID:3101HUMSCSP5040, CCRID:4201HUM-CCTCC00032, CCRID:5301HUM-KCB89023YJ, CCTCC:GDC0032, ChEMBL-Cells:CHEMBL3308499, ChEMBL-Targets:CHEMBL614181, CLS:300395, ECACC:97112601, FCS-free:179-2-338-1-16-3, GEO:GSM248209, GEO:GSM248210, GEO:GSM520665, GEO:GSM520666, GEO:GSM520667, GEO:GSM579888, GEO:GSM579889, GEO:GSM607969, GEO:GSM3738752, GEO:GSM3738753, IBRC:C10313, ICLC:HL95001, IZSLER:BS CL 68, JCRB:IFO50073, JCRB:JCRB9008, KCB:KCB 200412YJ, KCB:KCB 89023YJ, KCLB:10171, Lonza:52, NCBI_Iran:C125, PRIDE:PXD001909, PRIDE:PXD013120, PRIDE:PXD023286, PubChem_Cell_line:CVCL_0440, RCB:RCB0211, RCB:RCB0218, Wikidata:Q3273166 |
|
|
CVCL_0440 |
2026-09-12 05:49:22 |
2876 |
MS751
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_4996
|
Homo sapiens (Human)
|
Human papillomavirus-related cervical squamous cell carcinoma
|
Virology: Contains a partial HPV45 genome., Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:327080 PMID:2990217 PMID:3518877 PMID:6935474 PMID:7459858 PMID:9049418 PMID:15531914 PMID:24134916 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:29156801 PMID:30894373 PMID:35839778
|
Cancer cell line
|
Female |
MS-751, MS 751 |
|
|
CLO:CLO_0007878, EFO:EFO_0006456, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-3610, ATCC:HTB-34, BioSample:SAMN03472742, BioSample:SAMN03473089, cancercelllines:CVCL_4996, CCRID:3101HUMSCSP537, CCRID:3101HUMTCHu178, Cell_Model_Passport:SIDM00638, CLS:305115, Cosmic:928910, Cosmic:1071904, Cosmic:1131523, Cosmic:1176606, Cosmic:1193034, Cosmic:1201772, Cosmic:1995514, Cosmic:2816216, Cosmic-CLP:1240179, DepMap:ACH-001360, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:1240179, GEO:GSM113865, GEO:GSM253301, GEO:GSM675737, GEO:GSM685439, GEO:GSM1670135, IARC_TP53:27233, IGRhCellID:MS751, LINCS_LDP:LCL-1306, PharmacoDB:MS751_967_2019, PRIDE:PXD030304, Progenetix:CVCL_4996, Ubigene:YC-C123, Wikidata:Q54906811 |
|
|
CVCL_4996 |
2026-09-12 05:49:27 |
1 |
MS-1 [Human lung carcinoma]
Resource Report
Resource Website
Discontinued Discontinued
|
RRID:CVCL_1429
|
Homo sapiens (Human)
|
Lung small cell carcinoma
|
Population: Japanese., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:9183634 PMID:15016488 PMID:15901131 PMID:20164919 PMID:20215515 PMID:22313637 PMID:25877200 PMID:27397505 PMID:30894373 PMID:35839778 PMID:38639832
|
Cancer cell line
|
Male |
MS-1-L, MS1, Ms1 |
|
|
CLO:CLO_0037031, CLO:CLO_0050048, EFO:EFO_0002836, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-3610, BioSample:SAMN03470995, cancercelllines:CVCL_1429, Cell_Model_Passport:SIDM00245, ChEMBL-Cells:CHEMBL3308892, ChEMBL-Targets:CHEMBL2366125, Cosmic:753594, Cosmic:1212198, Cosmic:1571744, Cosmic:1656910, Cosmic-CLP:753594, DepMap:ACH-001958, EGA:EGAS00001000978, GDSC:753594, GEO:GSM17311, GEO:GSM827217, GEO:GSM1670134, IARC_TP53:21517, JCRB:JCRB1081, JCRB:NIHS0320, JCRB:NIHS0353, LINCS_LDP:LCL-1835, PharmacoDB:MS1_966_2019, PRIDE:PXD030304, Progenetix:CVCL_1429, PubChem_Cell_line:CVCL_1429, RCB:RCB0725, Wikidata:Q54906752 |
|
|
CVCL_1429 |
2026-09-12 05:49:26 |
0 |
MT-3 [Human contaminated breast cancer]
Resource Report
Resource Website
Contaminated
|
RRID:CVCL_2129
|
Homo sapiens (Human)
|
Colon adenocarcinoma
|
Population: Caucasian., Part of: MD Anderson Cell Lines Project., Problematic cell line: Contaminated. Shown to be a LS174T derivative (PubMed=25877200; DSMZ). Originally thought to originate from a breast carcinoma..
|
PMID:1446057 PMID:9150904 PMID:11044355 PMID:12661003 PMID:12800145 PMID:15677628 PMID:20215515 PMID:24176112 PMID:25485619 PMID:25877200 PMID:26589293 PMID:28196595
|
Cancer cell line
|
Female |
MT3 |
|
|
CLO:CLO_0007890, EFO:EFO_0002241, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-2706, BioSample:SAMN03472975, BioSample:SAMN03473582, BioSample:SAMN06481118, cancercelllines:CVCL_2129, DSMZ:ACC-403, DSMZCellDive:ACC-403, EGA:EGAS00001000610, GEO:GSM115102, GEO:GSM217592, GEO:GSM412073, GEO:GSM412084, GEO:GSM412093, GEO:GSM412098, GEO:GSM412106, GEO:GSM412110, GEO:GSM459700, GEO:GSM474280, GEO:GSM474281, GEO:GSM476484, GEO:GSM476485, GEO:GSM478311, GEO:GSM478312, GEO:GSM478314, GEO:GSM478315, GEO:GSM478320, GEO:GSM478321, GEO:GSM783977, GEO:GSM844610, GEO:GSM847419, GEO:GSM847498, GEO:GSM1172986, IGRhCellID:MT3, LINCS_HMS:50031, LINCS_LDP:LCL-1473, PharmacoDB:MT3_969_2019, Progenetix:CVCL_2129, Wikidata:Q54906937 |
cvcl_1384 |
|
CVCL_2129 |
2026-09-12 05:49:31 |
0 |
MG-63
Resource Report
Resource Website
1000+ mentions
|
RRID:CVCL_0426
|
Homo sapiens (Human)
|
Osteosarcoma
|
Caution: The reported STR profile from CLS of this cell line was changed in June 2019. Seven conflicts with other sources were resolved., Anecdotal: Have been flown in space on Foton-10 and Foton-M3 to study if differentiation is altered in microgravity (PubMed=9144345; PubMed=9600771; PubMed=24903274)., Characteristics: Can be induced to differentiate by treating the cells with 1,25-dihydroxyvitamin D3 and TGF-beta. The cells do not differentiate into the mineralized state, but stop at the matrix maturation stage (PubMed=1577731)., Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Space-flown cell line (cellonaut).
|
PMID:218153 PMID:883813 PMID:1577731 PMID:2233717 PMID:2823272 PMID:7873286 PMID:8617485 PMID:9144345 PMID:9600771 PMID:12645653 PMID:15736406 PMID:17981215 PMID:19160414 PMID:19363654 PMID:19787792 PMID:20164919 PMID:20215515 PMID:21519327 PMID:22460905 PMID:23129384 PMID:23144859 PMID:24903274 PMID:25382592 PMID:25485619 PMID:25877200 PMID:26320182 PMID:26589293 PMID:27397505 PMID:28196595 PMID:29334376 PMID:30894373 PMID:31068700 PMID:35839778 PMID:36480329
|
Cancer cell line
|
Male |
M-G63, MG63 |
|
|
BTO:BTO_0001596, CLO:CLO_0007699, CLO:CLO_0007701, CLO:CLO_0050808, EFO:EFO_0002234, MCCL:MCC:0000323, CLDB:cl3462, CLDB:cl3463, CLDB:cl3464, CLDB:cl3465, CLDB:cl4934, AddexBio:C0004007/4991, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:CRL-1427, BCRC:60279, BCRJ:0173, BioSample:SAMN03471910, BioSample:SAMN03472771, BioSample:SAMN10988146, cancercelllines:CVCL_0426, CCRID:1101HUM-PUMC000080, CCRID:3101HUMTCHu124, CCRID:4201HUM-CCTCC00074, CCTCC:GDC0074, Cell_Model_Passport:SIDM00525, ChEMBL-Cells:CHEMBL3308498, ChEMBL-Targets:CHEMBL614347, CLS:300441, Cosmic:755310, Cosmic:908131, Cosmic:931036, Cosmic:931913, Cosmic:1044085, Cosmic:1070844, Cosmic:1074394, Cosmic:1082504, Cosmic:1188475, Cosmic:1529903, Cosmic-CLP:908131, DepMap:ACH-000359, ECACC:86051601, EGA:EGAS00001000610, EGA:EGAS00001000978, ENCODE:ENCBS091SUW, ENCODE:ENCBS462PMF, GDSC:908131, GEO:GSM170251, GEO:GSM320828, GEO:GSM827317, GEO:GSM879217, GEO:GSM887314, GEO:GSM888390, GEO:GSM1670103, GEO:GSM1915004, GEO:GSM1915005, GEO:GSM1915006, GEO:GSM1915007, GEO:GSM1915033, GEO:GSM1915034, GEO:GSM2635311, GEO:GSM2635312, IARC_TP53:21498, IARC_TP53:21660, ICLC:HTL99003, IGRhCellID:MG63, IZSLER:BS TCL 40, JCRB:IFO50108, KCB:KCB 200528YJ, KCLB:21427, LiGeA:CCLE_145, LINCS_LDP:LCL-1428, Lonza:872, NCBI_Iran:C555, PharmacoDB:MG63_924_2019, PRIDE:PXD030304, Progenetix:CVCL_0426, PubChem_Cell_line:CVCL_0426, RCB:RCB1890, TKG:TKG 0294, TOKU-E:2429, Wikidata:Q54905408 |
|
|
CVCL_0426 |
2026-09-12 05:48:51 |
2532 |
MHH-NB-11
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1412
|
Homo sapiens (Human)
|
Neuroblastoma
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:3218965 PMID:11668190 PMID:20164919 PMID:22460905 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:30894373 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Male |
MHH-NB11, MHHNB11 |
|
|
CLO:CLO_0007719, EFO:EFO_0006651, CLDB:cl3479, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:546, BioSample:SAMN03473088, BioSample:SAMN10988427, cancercelllines:CVCL_1412, Cell_Model_Passport:SIDM00387, ChEMBL-Cells:CHEMBL3308310, ChEMBL-Targets:CHEMBL2366185, Cosmic:908135, Cosmic:2485948, Cosmic-CLP:908135, DepMap:ACH-000078, DSMZ:ACC-157, DSMZCellDive:ACC-157, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:908135, GEO:GSM887319, GEO:GSM888395, GEO:GSM1366409, GEO:GSM1670107, GEO:GSM3145573, GEO:GSM3145723, IARC_TP53:21502, LiGeA:CCLE_041, LINCS_LDP:LCL-1975, PharmacoDB:MHHNB11_929_2019, PRIDE:PXD030304, Progenetix:CVCL_1412, PubChem_Cell_line:CVCL_1412, Wikidata:Q54905545 |
|
|
CVCL_1412 |
2026-09-12 05:48:54 |
5 |
MKN7
Resource Report
Resource Website
10+ mentions
Discontinued Discontinued
|
RRID:CVCL_1417
|
Homo sapiens (Human)
|
Gastric tubular adenocarcinoma
|
Caution: TP53 mutation indicated incorrectly as being at p.Ile251Leu (c.751A>C) in PubMed=15900046., Population: Japanese., Part of: JFCR45 cancer cell line panel., Part of: JFCR39 cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1933850 PMID:3962675 PMID:6862145 PMID:11107048 PMID:15723654 PMID:15767549 PMID:15900046 PMID:20164919 PMID:20215515 PMID:22336246 PMID:22460905 PMID:24587255 PMID:24807215 PMID:25343454 PMID:25485619 PMID:25877200 PMID:25984343 PMID:26589293 PMID:27397505 PMID:29435981 PMID:30894373 PMID:31068700 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Male |
MKN-7, MKN 7 |
|
|
BTO:BTO_0002382, CLO:CLO_0050805, EFO:EFO_0002895, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioSample:SAMN03472197, BioSample:SAMN03473201, BioSample:SAMN10988431, cancercelllines:CVCL_1417, Cell_Model_Passport:SIDM00560, CGH-DB:118-1, CGH-DB:9020-4, ChEMBL-Cells:CHEMBL3307377, ChEMBL-Targets:CHEMBL614355, CLS:305104, Cosmic:733175, Cosmic:848370, Cosmic:877040, Cosmic:888825, Cosmic:889106, Cosmic:897533, Cosmic:922693, Cosmic:924250, Cosmic:926112, Cosmic:968347, Cosmic:983725, Cosmic:1007601, Cosmic:1066229, Cosmic:1093297, Cosmic:1187284, Cosmic:1223587, Cosmic:1436024, Cosmic:1460708, Cosmic:1482077, Cosmic:1518242, Cosmic:1995511, Cosmic:2807634, Cosmic-CLP:924250, DepMap:ACH-000678, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:924250, GEO:GSM552365, GEO:GSM562401, GEO:GSM827584, GEO:GSM844608, GEO:GSM887326, GEO:GSM888402, GEO:GSM1237677, GEO:GSM1237702, GEO:GSM1670114, IARC_TP53:13723, IARC_TP53:21641, JCRB:FDSC0010, JCRB:JCRB0082, JCRB:JCRB1025, LiGeA:CCLE_388, LINCS_LDP:LCL-1885, PharmacoDB:MKN7_939_2019, PRIDE:PXD030304, Progenetix:CVCL_1417, PubChem_Cell_line:CVCL_1417, RCB:RCB0999, RCB:RCB3687, TKG:TKG 0228, Wikidata:Q54905831 |
|
|
CVCL_1417 |
2026-09-12 05:49:03 |
15 |
ML-2
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_1418
|
Homo sapiens (Human)
|
Adult acute myeloid leukemia
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2985879 PMID:3159941 PMID:3458526 PMID:3874327 PMID:6091813 PMID:14671638 PMID:15843827 PMID:16408098 PMID:16969076 PMID:20164919 PMID:20215515 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:30894373 PMID:35839778
|
Cancer cell line
|
Male |
ML2 |
|
|
BTO:BTO_0001885, CLO:CLO_0007736, EFO:EFO_0002238, CLDB:cl3490, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-3610, BioSample:SAMN03472168, cancercelllines:CVCL_1418, Cell_Model_Passport:SIDM00441, ChEMBL-Cells:CHEMBL3307604, ChEMBL-Targets:CHEMBL614356, Cosmic:787454, Cosmic:850389, Cosmic:908141, Cosmic:975271, Cosmic:999728, Cosmic:1012092, Cosmic:1078727, Cosmic:1078739, Cosmic:1151785, Cosmic:1181602, Cosmic:1281329, Cosmic:1524834, Cosmic:2131545, Cosmic:2391904, Cosmic:2750863, Cosmic-CLP:908141, DepMap:ACH-002273, DSMZ:ACC-15, DSMZCellDive:ACC-15, EGA:EGAS00001000610, EGA:EGAS00001000978, EGA:EGAS00001002554, GDSC:908141, GEO:GSM236791, GEO:GSM236827, GEO:GSM482497, GEO:GSM1374683, GEO:GSM1446737, GEO:GSM1670116, IGRhCellID:ML2, LINCS_LDP:LCL-1060, PharmacoDB:ML2_942_2019, PRIDE:PXD030304, Progenetix:CVCL_1418, PubChem_Cell_line:CVCL_1418, Wikidata:Q54905843 |
|
|
CVCL_1418 |
2026-09-12 05:49:03 |
17 |
MKN74
Resource Report
Resource Website
100+ mentions
|
RRID:CVCL_2791
|
Homo sapiens (Human)
|
Gastric tubular adenocarcinoma
|
Population: Japanese., Part of: MD Anderson Cell Lines Project., Part of: JFCR45 cancer cell line panel., Part of: JFCR39 cancer cell line panel., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1370612 PMID:1933850 PMID:3962675 PMID:6862145 PMID:9290701 PMID:11107048 PMID:11314020 PMID:15723654 PMID:15767549 PMID:15900046 PMID:20215515 PMID:22336246 PMID:22460905 PMID:24587255 PMID:24807215 PMID:25343454 PMID:25485619 PMID:25877200 PMID:25960936 PMID:26589293 PMID:28196595 PMID:29435981 PMID:30894373 PMID:31068700
|
Cancer cell line
|
Male |
MKN-74, MKN 74 |
|
|
BTO:BTO_0002383, CLO:CLO_0050798, EFO:EFO_0002834, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, BioSample:SAMN01821701, BioSample:SAMN03473122, BioSample:SAMN10987828, cancercelllines:CVCL_2791, Cell_Model_Passport:SIDM00248, CGH-DB:121-1, CGH-DB:9023-4, ChEMBL-Cells:CHEMBL3307287, ChEMBL-Targets:CHEMBL614048, CLS:300490, Cosmic:685597, Cosmic:801340, Cosmic:848148, Cosmic:848372, Cosmic:873712, Cosmic:877043, Cosmic:887253, Cosmic:888828, Cosmic:897536, Cosmic:918498, Cosmic:922695, Cosmic:926115, Cosmic:983728, Cosmic:1007603, Cosmic:1067209, Cosmic:1090462, Cosmic:1093300, Cosmic:1122338, Cosmic:1187285, Cosmic:1223590, Cosmic:1436027, Cosmic:1460709, Cosmic:1477424, Cosmic:1518244, Cosmic:2484974, Cosmic:2807635, DepMap:ACH-000758, EGA:EGAS00001000610, GEO:GSM562418, GEO:GSM827533, GEO:GSM844609, GEO:GSM887325, GEO:GSM888401, GEO:GSM1374682, IARC_TP53:21642, IARC_TP53:30196, JCRB:JCRB0255, KCLB:80104, LiGeA:CCLE_606, LINCS_LDP:LCL-1536, PharmacoDB:MKN74_940_2019, Progenetix:CVCL_2791, PubChem_Cell_line:CVCL_2791, RCB:RCB1002, Wikidata:Q54905833 |
|
|
CVCL_2791 |
2026-09-12 05:49:03 |
185 |
MMAc
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_5951
|
Homo sapiens (Human)
|
Melanoma
|
Population: Japanese., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:25877200
|
Cancer cell line
|
Female |
MMAC |
|
|
CLO:CLO_0050087, BioSample:SAMN03472870, cancercelllines:CVCL_5951, Cell_Model_Passport:SIDM00246, DepMap:ACH-002084, RCB:RCB0808, Wikidata:Q54906200 |
|
|
CVCL_5951 |
2026-09-12 05:49:13 |
1 |
MOLM-13
Resource Report
Resource Website
100+ mentions
|
RRID:CVCL_2119
|
Homo sapiens (Human)
|
Adult acute monocytic leukemia
|
Population: Japanese., Part of: MD Anderson Cell Lines Project., Part of: LL-100 blood cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:9305600 PMID:10233379 PMID:10637496 PMID:10739008 PMID:11226526 PMID:12529668 PMID:14504097 PMID:14671638 PMID:15381384 PMID:16408098 PMID:22354205 PMID:22460905 PMID:23955599 PMID:25877200 PMID:25984343 PMID:27397505 PMID:27750403 PMID:28052028 PMID:28109323 PMID:28196595 PMID:29491412 PMID:30285677 PMID:30629668 PMID:30894373 PMID:31068700 PMID:31160637 PMID:31978347 PMID:33669837 PMID:35839778 PMID:36982453
|
Cancer cell line
|
Male |
MOLM13, Molm13, Molm 13 |
|
|
BTO:BTO_0004175, CLO:CLO_0009848, EFO:EFO_0022694, AddexBio:C0003003/60, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ArrayExpress:E-MTAB-7721, ArrayExpress:E-MTAB-7722, BioGRID_ORCS_Cell_line:403, BioSample:SAMN03473102, BioSample:SAMN10988379, cancercelllines:CVCL_2119, Cell_Model_Passport:SIDM00437, ChEMBL-Cells:CHEMBL3706573, ChEMBL-Targets:CHEMBL3706572, Cosmic:787417, Cosmic:947367, Cosmic:975274, Cosmic:996319, Cosmic:998754, Cosmic:999722, Cosmic:999772, Cosmic:1012095, Cosmic:1037671, Cosmic:1078734, Cosmic:1150897, Cosmic:1152711, Cosmic:1187863, Cosmic:1197930, Cosmic:1278778, Cosmic:1281332, Cosmic:1308222, Cosmic:1465952, Cosmic:1696139, Cosmic:1741687, Cosmic:2089664, Cosmic:2131546, Cosmic:2306220, Cosmic:2750864, Cosmic:2842299, Cosmic-CLP:1330947, DepMap:ACH-000362, DSMZ:ACC-554, DSMZCellDive:ACC-554, EGA:EGAS00001000978, EGA:EGAS00001002554, GDSC:1330947, GEO:GSM482509, GEO:GSM887329, GEO:GSM888405, GEO:GSM1374688, GEO:GSM1374689, GEO:GSM1446738, GEO:GSM1670124, GEO:GSM2124117, GEO:GSM2716691, GEO:GSM2716692, GEO:GSM2716748, GEO:GSM2716749, GEO:GSM2716750, GEO:GSM2716751, IARC_TP53:30123, JCRB:JCRB1810, LiGeA:CCLE_282, LINCS_LDP:LCL-1061, PharmacoDB:MOLM13_950_2019, PRIDE:PXD030304, Progenetix:CVCL_2119, PubChem_Cell_line:CVCL_2119, Wikidata:Q54906320 |
|
|
CVCL_2119 |
2026-09-12 05:49:16 |
422 |
MOLP-8
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_2124
|
Homo sapiens (Human)
|
Plasma cell myeloma
|
Characteristics: Produces IgD lambda., Population: Japanese., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:15203285 PMID:22460905 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:28196595 PMID:30285677 PMID:30894373 PMID:31068700 PMID:32123307 PMID:35839778
|
Cancer cell line
|
Male |
MOLP8 |
|
|
CLO:CLO_0009849, EFO:EFO_0006654, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioSample:SAMN03472939, BioSample:SAMN10989574, cancercelllines:CVCL_2124, Cell_Model_Passport:SIDM00434, CLS:304082, Cosmic-CLP:1330950, DepMap:ACH-000745, DSMZ:ACC-569, DSMZCellDive:ACC-569, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:1330950, GEO:GSM562816, GEO:GSM887333, GEO:GSM888409, GEO:GSM1374691, GEO:GSM1670125, IARC_TP53:30124, LiGeA:CCLE_271, LINCS_LDP:LCL-2047, PharmacoDB:MOLP8_954_2019, PRIDE:PXD030304, Progenetix:CVCL_2124, Wikidata:Q54906340 |
|
|
CVCL_2124 |
2026-09-12 05:49:16 |
10 |
MOLM-16
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_2120
|
Homo sapiens (Human)
|
Adult acute myeloid leukemia with minimal differentiation
|
Population: Japanese., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:12526922 PMID:16408098 PMID:22460905 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:30285677 PMID:30629668 PMID:30894373 PMID:31068700 PMID:31978347 PMID:35839778 PMID:36982453
|
Cancer cell line
|
Female |
MOLM16 |
|
|
BTO:BTO_0004176, EFO:EFO_0006652, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioSample:SAMN03473252, BioSample:SAMN10989567, cancercelllines:CVCL_2120, Cell_Model_Passport:SIDM00435, ChEMBL-Cells:CHEMBL4879543, Cosmic:787457, Cosmic:975275, Cosmic:1012096, Cosmic:1281334, Cosmic:2131560, Cosmic:2306221, Cosmic:2750865, Cosmic-CLP:1330948, DepMap:ACH-000369, DSMZ:ACC-555, DSMZCellDive:ACC-555, EGA:EGAS00001000610, EGA:EGAS00001000978, EGA:EGAS00001002554, GDSC:1330948, GEO:GSM887330, GEO:GSM888406, GEO:GSM1374690, GEO:GSM1446739, IARC_TP53:28318, JCRB:JCRB1815, LiGeA:CCLE_524, PharmacoDB:MOLM16_951_2019, PRIDE:PXD030304, Progenetix:CVCL_2120, Wikidata:Q54906324 |
|
|
CVCL_2120 |
2026-09-12 05:49:16 |
5 |
MOG-G-CCM
Resource Report
Resource Website
|
RRID:CVCL_2613
|
Homo sapiens (Human)
|
Anaplastic astrocytoma
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:3254724 PMID:6200130 PMID:7518347 PMID:7591247 PMID:20164919 PMID:20215515 PMID:25877200 PMID:27397505 PMID:30894373 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Sex unspecified |
MOGGCCM, GO-G-CCM, G-CCM, CCM, Medical Oncology Glascow-Glioma-CCM |
|
|
CLO:CLO_0007817, CLDB:cl3512, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-3610, BioSample:SAMN03470986, BioSample:SAMN10988381, cancercelllines:CVCL_2613, Cell_Model_Passport:SIDM00532, ChEMBL-Cells:CHEMBL3308456, Cosmic:687450, Cosmic:908144, Cosmic:2367538, Cosmic-CLP:908144, DepMap:ACH-001125, ECACC:86022702, EGA:EGAS00001000978, GDSC:908144, GEO:GSM827349, GEO:GSM1374686, GEO:GSM1670122, IARC_TP53:21511, LINCS_LDP:LCL-1396, PharmacoDB:MOGGCCM_948_2019, PRIDE:PXD030304, Progenetix:CVCL_2613, Wikidata:Q54906311 |
|
|
CVCL_2613 |
2026-09-12 05:49:15 |
0 |